Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis

Launched by NAIK VIETTI VIOLI · Aug 23, 2024

Keywords

ClinConnect Summary

This clinical trial is comparing two methods of performing abdominal ultrasounds in patients with viral hepatitis. The study is looking at how a newer, ultraportable ultrasound device that can send images remotely (called TUP) works compared to the traditional ultrasound (CUS). The goal is to see if the new device is just as effective for diagnosing and monitoring hepatitis.

To be eligible for this study, participants must be adults who have viral hepatitis and are scheduled for an ultrasound. They will need to sign a consent form to join the trial. However, people who have trouble understanding the study or following its procedures, or who have been part of the study before, cannot participate. If you join the trial, you can expect to have your ultrasound done using one of the two methods, and you'll help researchers understand which one works better for patients like you. Your participation could contribute to improving how hepatitis is diagnosed in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed Consent signed by the subject
• • All adult patients with viral hepatitis for which an ultrasound is planned
• Exclusion Criteria:
• • Known or suspected non-compliance
• • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
• • Previous enrollment into the current study